Literature DB >> 9234332

FDG uptake, tumor proliferation and expression of glycolysis associated genes in animal tumor models.

U Haberkorn1, S I Ziegler, F Oberdorfer, H Trojan, D Haag, P Peschke, M R Berger, A Altmann, G van Kaick.   

Abstract

To determine the influence of tumor cell proliferation and changes in the genetic program in malignant cells on the fluorodeoxyglucose (FDG) uptake we performed PET studies in several animal tumors: spontaneous mammary fibroadenoma, chemically-induced mammary adenocarcinoma and Dunning prostate adenocarcinoma. The expression of the glucose transporter (GLUT1) and of hexokinase (Hk) was measured using 32P-labeled cDNA probes and densitometry. Furthermore the proliferative activity was determined with one-dimensional flow cytometry. The FDG uptake and the proliferation parameters were not correlated. The normalized amounts of GLUT and Hk mRNA were lower in spontaneous fibroadenomas and prostate tumors than in chemically induced mammary. The FDG uptake was correlated to GLUT1 expression with r = 0.83 and to Hk expression with r = 0.77. Multiple regression analysis revealed a relation of FDG uptake to GLUT1 and HK with r = 0.87. Our results show that the FDG uptake in our study was related not to differences in proliferation, but rather to differences in the transcription of glycolysis associated genes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 9234332     DOI: 10.1016/0969-8051(94)90162-7

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  31 in total

1.  Requirements for clinical PET: comparisons within Europe.

Authors:  Michael Bedford; Michael N Maisey
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02       Impact factor: 9.236

Review 2.  [18F]FLT-PET in oncology: current status and opportunities.

Authors:  Lukas B Been; Albert J H Suurmeijer; David C P Cobben; Pieter L Jager; Harald J Hoekstra; Philip H Elsinga
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-12       Impact factor: 9.236

3.  [18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung.

Authors:  Marcelo Mamede; Tatsuya Higashi; Masanori Kitaichi; Koichi Ishizu; Takayoshi Ishimori; Yuji Nakamoto; Kazuhiro Yanagihara; Mio Li; Fumihiro Tanaka; Hiromi Wada; Toshiaki Manabe; Tsuneo Saga
Journal:  Neoplasia       Date:  2005-04       Impact factor: 5.715

4.  Glucose-6-phosphatase Expression-Mediated [18F]FDG Efflux in Murine Inflammation and Cancer Models.

Authors:  Mi Jeong Kim; Chul-Hee Lee; Youngeun Lee; Hyewon Youn; Keon Wook Kang; JoonHo Kwon; Abass Alavi; Sean Carlin; Gi Jeong Cheon; June-Key Chung
Journal:  Mol Imaging Biol       Date:  2019-10       Impact factor: 3.488

5.  Dynamic PET with (18)F-Deoxyglucose (FDG) and quantitative assessment with a two-tissue compartment model reflect the activity of glucose transporters and hexokinases in patients with colorectal tumors.

Authors:  Ludwig G Strauss; Dirk Koczan; Sven Klippel; Leyun Pan; Stefan Willis; Christos Sachpekidis; Antonia Dimitrakopoulou-Strauss
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-09-19

6.  An evaluation of 2-deoxy-2-[18F]fluoro-D-glucose and 3'-deoxy-3'-[18F]-fluorothymidine uptake in human tumor xenograft models.

Authors:  Heather Keen; Bernd Pichler; Damaris Kukuk; Olivier Duchamp; Olivier Raguin; Aoife Shannon; Nichola Whalley; Vivien Jacobs; Juliana Bales; Neill Gingles; Sally-Ann Ricketts; Stephen R Wedge
Journal:  Mol Imaging Biol       Date:  2012-06       Impact factor: 3.488

7.  Using positron emission tomography with [(18)F]FDG to predict tumor behavior in experimental colorectal cancer.

Authors:  B M Burt; J L Humm; D A Kooby; O D Squire; S Mastorides; S M Larson; Y Fong
Journal:  Neoplasia       Date:  2001 May-Jun       Impact factor: 5.715

8.  Evaluation of the Metabolic Response to Cyclopamine Therapy in Pancreatic Cancer Xenografts Using a Clinical PET-CT System.

Authors:  Hany Kayed; Patrick Meyer; Yong He; Bettina Kraenzlin; Christian Fink; Norbert Gretz; Stefan O Schoenberg; Maliha Sadick
Journal:  Transl Oncol       Date:  2012-10-01       Impact factor: 4.243

Review 9.  18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization.

Authors:  Hossein Jadvar; Abass Alavi; Sanjiv S Gambhir
Journal:  J Nucl Med       Date:  2009-10-16       Impact factor: 10.057

10.  Proliferation-dependent changes in amino acid transport and glucose metabolism in glioma cell lines.

Authors:  Toshio Sasajima; Tadashi Miyagawa; Takamitsu Oku; Juri G Gelovani; Ronald Finn; Ronald Blasberg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-05-13       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.